New Mountain Capital Enters Partnership with Topix Pharmaceuticals
Ropes & Gray represented New Mountain Capital, LLC in its partnership with Topix Pharmaceuticals, Inc., a provider of innovative therapeutic and cosmetic skin care products. New Mountain will provide Topix with significant financial and strategic resources to support future growth initiatives, which include new product development and acquisitions.
Based in Amityville, N.Y., Topix has developed, manufactured and marketed highly innovative and clinically-validated topical skin care products for over 30 years. Topix’s product portfolio addresses a wide array of skin health conditions and includes leading brands Replenix, Citrix, Glycolix, and ReBrightalyze as well as customized, private label solutions for the professionally dispensed market.
New Mountain Capital manages private equity, public equity, and credit funds with over $15 billion in aggregate capital commitments.
The partnership was announced July 11.
The Ropes & Gray team advising New Mountain Capital included mergers & acquisitions and private equity partner John Sorkin (New York), executive compensation & employee benefits partner Renata Ferrari (Boston) and tax partner Adam Greenwood (New York).